Clinical Trial: A Study on the Efficacy and Safety of Aumolertinib Combined with Microwave Ablation in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations: A Retrospective Real-World Study (China)

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Study on the Efficacy and Safety of Aumolertinib Combined with Microwave Ablation in the Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) with EGFR Mutations: A Retrospective Real-World Study'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133050

Registration Time: 2026/09/21

Type: Observational study

Primary Sponsor: Tianjin Hansen Cloud Comprehensive Clinic. Tianjin Hansen Cloud Comprehensive Clinic Internet Hospital.

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=296673

Published by HT Digital Content Services with permission from Healt...